Showing results (91-100 of 288) with videos related to
Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skinMichael Poulsen, Euan Walpole, Jennifer Harvey, et al.Physics and Imaging in Radiation Oncology|March 13, 2026
A deep learning approach for predicting linear accelerator output settings in automated radiotherapy planning of oligometastatic cancerMathieu Gaudreault, Lachlan McIntosh, Katrina Woodford, et al.Cancer Gene Therapy|December 27, 2022
HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancerAhmed M Mehdi, Chenhao Zhou, Gavin Turrell, et al.International Journal of Radiation Oncology, Biology, Physics|November 13, 2009
Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skinMatthew Foote, Jennifer Harvey, Sandro Porceddu, et al.American Journal of Clinical Oncology|June 1, 2002
Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagusMichael Jefford, Guy C Toner, Jennifer G Smith, et al.Expert Review of Anticancer Therapy|July 13, 2006
Head and neck cancer: past, present and futureDavid Chin, Glen M Boyle, Sandro Porceddu, et al.Frontiers in Oncology|May 3, 2021
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell CarcinomaAnnette M Lim, Karda Cavanagh, Rodney J Hicks, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment studyMartin Reck, Nico van Zandwijk, Cesare Gridelli, et al.International Journal of Radiation Oncology, Biology, Physics|August 30, 2005
Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?Michael G Poulsen, Danny Rischin, Ian Porter, et al.Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.Pageof 29